#4-67E.Unlocking Early Pregnancy Care: NSAID Exposure and Fetal Safety (PLOSMed, 2026)

Are you often faced with the clinical dilemma of safely managing pain and fever in early pregnancy? This episode delves into a large retrospective cohort study of over 264,000 pregnancies, which evaluates the association between first-trimester exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) and the risk of major congenital malformations (MCMs).1more_horiz Utilizing comprehensive data from a southern Israeli pregnancy registry, the researchers demonstrated that NSAID exposure does not increase the risk of overall or organ-specific MCMs. The most critical clinical takeaway is the robust, reassuring evidence supporting the safety of individual NSAIDs, such as ibuprofen and diclofenac, with no dose-response risk observed. However, when critically appraising this study, clinicians must consider the potential for exposure misclassification bias, as some over-the-counter ibuprofen use might not be captured in the dispensation records. For physicians, this paper is highly significant as it directly impacts daily practice, providing the necessary evidence to confidently guide treatment decisions and counsel pregnant patients who require effective management of pain and fever during their first trimester.

Citation: Hasidim AA, Daniel S, et al. First-trimester nonsteroidal anti-inflammatory drugs exposure and risk of major congenital malformations: A retrospective register-based cohort study. PLOS Medicine. 2026. DOI: 10.1371/journal.pmed.1005063910

Disclaimer: This audio summary is based on personal interpretation and does not guarantee the exact content of the original paper. Please refer to the original article for details.